Weight Loss Drugs Face Coverage Crisis | College Basketball News

Weight-loss meds like Zepbound and Wegovy are flying off shelves, but insurance coverage is falling short—over 114 million people can’t get Zepbound covered, and 88% of those with partial coverage face extra hurdles like prior authorization. Plans keep shifting, leaving millions to pay full price out of pocket as science advances but access remains a major hurdle. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/b8f7430fac461624